Full-Time
Senior Manager
Pricing and Contracts
Granules
501-1,000 employees
Vertically integrated API and dosage manufacturer
Compensation Overview
$135k - $140k/yr
Chantilly, VA, USA
Remote
Bachelor's
 Accounting (1) |
|---|
Get referred to Granules
See people who can refer or advise you
- A bachelor’s degree in Market Research, Marketing, Project Management, or Supply Chain Management is required.
- At least five years of experience in the job offered or as a Pricing Analyst in the prescription and over-the-counter generic pharmaceutical business is required.
- Knowledge of pricing analysis, contract negotiation, product costing, contract compliance including most-favored-nation clauses, SAP enterprise resource planning, Power BI, Salesforce, pricing strategy development, revenue growth, and margin expansion is required.
- Review and analyze pharmaceutical pricing and rebate structures across the generic pharmaceutical business for prescription and over-the-counter products, and prepare pricing models for new business opportunities using product costing insights to recommend competitive pricing.
- Create profitability analyses for requests for proposals, price adjustments, and new product launches.
- Conduct pricing analysis using advanced Microsoft Excel and maintain pricing data in SAP enterprise resource planning, Power BI, and Salesforce.
- Develop and implement pricing and contract standard operating procedures to ensure adherence across Sales, Finance, and Customer Service.
- Compile monthly commercial operations status summaries for C-suite executives.
- Research and analyze new market opportunities and overall profitability to support pricing strategy development, revenue growth, and margin expansion initiatives.
- Review pricing accuracy in SAP enterprise resource planning and iContracts to ensure contract alignment and accurate customer pricing.
- Coordinate internal and external customer pricing communications.
- Ensure customer pricing complies with contractual terms, including management of most-favored-nation clauses, and support contract negotiations.
Granules India makes APIs, PFIs, and finished dosages, using large-scale, vertically integrated plants that control production from base chemicals to final medicines. Its products include common off-patent APIs like Paracetamol, Ibuprofen, Metformin, and Guaifenesin, and it is expanding into more complex areas such as MUPS, oncology, and peptide therapies with US FDA approvals. The company differentiates itself through full vertical integration, large scale, and a global manufacturing footprint that supports both contract manufacturing and its own branded products, offering supply security and cost competitiveness. Its goal is to deliver reliable, affordable medicines to customers worldwide while growing capabilities in complex therapies and pursuing sustainable practices like green chemistry.
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
2014
Get referred to Granules
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q4FY26 revenue rose 23% year over year to ₹14,706 million on April 29, 2026.
- Granules Life Sciences received NAI and VAI outcomes in 2026, validating expansion.
- Net debt fell to ₹4,021 million in FY26, strengthening funding for launches.
What critics are saying
- FDA's February 26, 2025 Gagillapur warning letter delays approvals for future U.S. launches.
- March 30, 2026 Chantilly FDA observations prove compliance problems persist across sites.
- If Gagillapur remediation fails, Granules loses its U.S. growth engine and valuation rerates lower.
What makes Granules unique
- Granules controls APIs, PFIs, and finished dosages, driving low-cost, high-volume manufacturing.
- The 2026 Senn Chemicals acquisition added peptides and Swiss CDMO capabilities.
- Granules Pharmaceuticals launched CNS generics, including lisdexamfetamine, with 180-day exclusivity in 2026.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours